Pregabalin Completed Phase 4 Trials for Epilepsies Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00288639Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER).